title: Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial.
authors.affiliation: a Department of Hematology , University Hospital Leuven , Leuven , Belgium.
authors.forename: Michel
authors.initials: M
authors.lastname: Delforge
authors.affiliation: a Department of Hematology , University Hospital Leuven , Leuven , Belgium.
authors.forename: Timothy
authors.initials: T
authors.lastname: Devos
authors.affiliation: b Department of Hematology and Bone Marrow Transplantation , RAMBAM Medical Center and Technion , Haifa , Israel.
authors.forename: Jacob
authors.initials: J
authors.lastname: Rowe
authors.affiliation: c Department of Hematology , Santa Lucia University Hospital , Cartagena , Spain.
authors.forename: Ignacio
authors.initials: I
authors.lastname: Español
authors.affiliation: d Cancer Care Services, Royal Brisbane and Women's hospital , Brisbane , Australia.
authors.forename: Simon T
authors.initials: ST
authors.lastname: Durrant
authors.affiliation: a Department of Hematology , University Hospital Leuven , Leuven , Belgium.
authors.forename: Jolien
authors.initials: J
authors.lastname: Raddoux
authors.affiliation: a Department of Hematology , University Hospital Leuven , Leuven , Belgium.
authors.forename: Marc
authors.initials: M
authors.lastname: Boogaerts
authors.affiliation: e Section for Stem Cell- and Immunotherapy, Medizinische Klinik , Kiel , Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Gramatzki
authors.affiliation: e Section for Stem Cell- and Immunotherapy, Medizinische Klinik , Kiel , Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Gunther